Clinical trials recruitment setup timeliness rate

STO-REC-STAT344J66T2 National
58%

United Kingdom · as of 8 Sep 2026

Clinical trials recruitment setup timeliness rate in United Kingdom stood at 58% as of 8 September 2026 (ABPI).

Original source
Publisher
ABPI
Authority tier
T2 National
Locator
UK areas of unrealised potential
Retrieved
17 Sep 2026
Status
Verified

What the source says

The gap has moved later in the process: only 58 per cent of industry trials opened to recruitment within 60 days of approval and recruitment fell by 25 per cent between 2022/23 and 2024/25, while the new network of 35 research delivery centres is outperforming the wider health system.

Verbatim extraction verified: The figure 58% is directly attested in the quoted passage (UK areas of unrealised potential).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_344J66GYJVV333X60WT9G7V99G
MLA
Association of the British Pharmaceutical Industry. "Green shoots for UK pharma investment, but delivery will decide whether they take root." 2026, https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_344J66GYJVV333X60WT9G7V99G.
Chicago
Association of the British Pharmaceutical Industry. "Green shoots for UK pharma investment, but delivery will decide whether they take root." 2026. https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_344J66GYJVV333X60WT9G7V99G.
BibTeX
@misc{abpi2026clinicalg7v99g, author = {{Association of the British Pharmaceutical Industry}}, title = {Green shoots for UK pharma investment, but delivery will decide whether they take root}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_344J66GYJVV333X60WT9G7V99G}, note = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STAT344J66 T2 National

Primary Source

Publisher
Association of the British Pharmaceutical Industry · homepage ↗
Authority tier
Tier 2 · National Official
Report
Green shoots for UK pharma investment, but delivery will decide whether they take root
Type
Press release
Published
Locator
UK areas of unrealised potential
Retrieved
17 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_344J66GYJVV333X60WT9G7V99G